Health-Related Quality of Life Impact from Adding Bevacizumab to Cisplatin-Pemetrexed in Malignant Pleural Mesothelioma in the MAPS IFCT-GFPC-0701 Phase III Trial

Guillaume Eberst; Amélie Anota; Arnaud Scherpereel; Julien Mazieres; Jacques Margery; Laurent Greillier; Clarisse Audigier-Valette; Denis Moro-Sibilot; Olivier Molinier; Hervé Léna; Frédéric Rivière; Isabelle Monnet; Valérie Gounant; Henri Janicot; Radj Gervais; Chrystelle Locher; Emilie Charton; Franck Morin; Gérard Zalcman; Virginie Westeel

doi:10.1158/1078-0432.ccr-18-2860

Health-Related Quality of Life Impact from Adding Bevacizumab to Cisplatin-Pemetrexed in Malignant Pleural Mesothelioma in the MAPS IFCT-GFPC-0701 Phase III Trial

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-18-2860 ◽

2019 ◽

Vol 25 (19) ◽

pp. 5759-5765 ◽

Cited By ~ 3

Author(s):

Guillaume Eberst ◽

Amélie Anota ◽

Arnaud Scherpereel ◽

Julien Mazieres ◽

Jacques Margery ◽

...

Keyword(s):

Quality Of Life ◽

Malignant Pleural Mesothelioma ◽

Phase Iii ◽

Pleural Mesothelioma ◽

Health Related Quality ◽

Phase Iii Trial ◽

Life Impact ◽

Related Quality ◽

Health Related

Download Full-text

Impact on health-related quality of life of the addition of bevacizumab to cisplatin-pemetrexed in malignant pleural mesothelioma in the MAPS phase III trial.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.8505 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 8505-8505 ◽

Cited By ~ 2

Author(s):

Virginie Westeel ◽

Guillaume Eberst ◽

Amelie Anota ◽

Arnaud Scherpereel ◽

Julien Mazieres ◽

...

Keyword(s):

Quality Of Life ◽

Malignant Pleural Mesothelioma ◽

Phase Iii ◽

Pleural Mesothelioma ◽

Health Related Quality ◽

Phase Iii Trial ◽

Related Quality ◽

Health Related

Download Full-text

Faculty Opinions recommendation of Lenalidomide, melphalan, and prednisone, followed by lenalidomide maintenance, improves health-related quality of life in newly diagnosed multiple myeloma patients aged 65 years or older: results of a randomized phase III trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717969674.793470152 ◽

2013 ◽

Author(s):

Christopher Steer

Keyword(s):

Quality Of Life ◽

Multiple Myeloma ◽

Phase Iii ◽

Newly Diagnosed ◽

Health Related Quality ◽

Phase Iii Trial ◽

Related Quality ◽

Health Related

Download Full-text

Health-related quality of life in patients with advanced renal cell carcinoma receiving pazopanib or placebo in a randomised phase III trial

European Journal of Cancer ◽

10.1016/j.ejca.2011.05.017 ◽

2012 ◽

Vol 48 (3) ◽

pp. 311-323 ◽

Cited By ~ 30

Author(s):

D. Cella ◽

A.S. Pickard ◽

M.S. Duh ◽

A. Guerin ◽

N. Mishagina ◽

...

Keyword(s):

Quality Of Life ◽

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Renal Cell ◽

Phase Iii ◽

Health Related Quality ◽

Phase Iii Trial ◽

Related Quality ◽

Health Related

Download Full-text

861 EFFECTS OF SUNITINIB VERSUS INTERFERON-ALFA IN HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC): RESULTS FROM A RANDOMIZED MULTINATIONAL PHASE III TRIAL

European Urology Supplements ◽

10.1016/s1569-9056(07)60856-2 ◽

2007 ◽

Vol 6 (2) ◽

pp. 238 ◽

Cited By ~ 3

Author(s):

D. Cella ◽

J.Z. Li ◽

J.C. Cappelleri ◽

A. Bushmakin ◽

S.T. Kim ◽

...

Keyword(s):

Quality Of Life ◽

Renal Cell Carcinoma ◽

Renal Cell ◽

Interferon Alfa ◽

Phase Iii ◽

Health Related Quality ◽

Phase Iii Trial ◽

Related Quality ◽

Health Related

Download Full-text

QLIF-25. EFFECT OF TUMOR TREATING FIELDS (TTFIELDS) ON HEALTH-RELATED QUALITY OF LIFE (HRQoL) IN NEWLY DIAGNOSED GLIOBLASTOMA. RESULTS OF THE EF-14 RANDOMIZED PHASE III TRIAL

Neuro-Oncology ◽

10.1093/neuonc/nox168.834 ◽

2017 ◽

Vol 19 (suppl_6) ◽

pp. vi206-vi206

Author(s):

Martin J B Taphoorn ◽

Linda Dirven ◽

Sophie Taillibert ◽

Jerôme Honnorat ◽

Thomas Chen ◽

...

Keyword(s):

Quality Of Life ◽

Phase Iii ◽

Newly Diagnosed ◽

Health Related Quality ◽

Phase Iii Trial ◽

Tumor Treating Fields ◽

Related Quality ◽

Health Related ◽

Newly Diagnosed Glioblastoma

Download Full-text

1108 POSTER Health-related quality of life (HRQOL) and kidney cancer-related symptoms in patients with metastatic renal cell carcinoma (mRCC) treated with sunitinib versus interferon (IFN)-alfa: results for European and US subsample analyses in a randomized, multinational phase III trial

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(07)70627-4 ◽

2007 ◽

Vol 5 (4) ◽

pp. 144

Author(s):

D. Cella ◽

J.Z. Li ◽

A.G. Bushmakin ◽

J.C. Cappelleri ◽

S.T. Kim ◽

...

Keyword(s):

Quality Of Life ◽

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Renal Cell ◽

Phase Iii ◽

Health Related Quality ◽

Phase Iii Trial ◽

Related Quality ◽

Health Related

Download Full-text

Time to Definitive Health-Related Quality of Life Score Deterioration in Patients with Resectable Metastatic Colorectal Cancer Treated with FOLFOX4 versus Sequential Dose-Dense FOLFOX7 followed by FOLFIRI: The MIROX Randomized Phase III Trial

PLoS ONE ◽

10.1371/journal.pone.0157067 ◽

2016 ◽

Vol 11 (6) ◽

pp. e0157067 ◽

Cited By ~ 8

Author(s):

Zeinab Hamidou ◽

Benoist Chibaudel ◽

Mohamed Hebbar ◽

Marine Hug de Larauze ◽

Thierry André ◽

...

Keyword(s):

Quality Of Life ◽

Colorectal Cancer ◽

Phase Iii ◽

Health Related Quality ◽

Phase Iii Trial ◽

Life Score ◽

Related Quality ◽

Health Related ◽

Dose Dense

Download Full-text

Health-related quality of life in patients with advanced renal cell carcinoma receiving pazopanib or placebo in a randomized phase III trial.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.9096 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 9096-9096 ◽

Cited By ~ 2

Author(s):

A. S. Pickard ◽

D. Cella ◽

M. S. Duh ◽

A. Guerin ◽

N. Mishagina ◽

...

Keyword(s):

Quality Of Life ◽

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Renal Cell ◽

Phase Iii ◽

Health Related Quality ◽

Phase Iii Trial ◽

Related Quality ◽

Health Related

Download Full-text

Impact of imatinib rechallenge on health-related quality of life in patients with TKI-refractory gastrointestinal stromal tumours: Sub-analysis of the placebo-controlled, randomised phase III trial (RIGHT)

European Journal of Cancer ◽

10.1016/j.ejca.2015.10.071 ◽

2016 ◽

Vol 52 ◽

pp. 201-208 ◽

Cited By ~ 4

Author(s):

Changhoon Yoo ◽

Min-Hee Ryu ◽

Byung-Ho Nam ◽

Baek-Yeol Ryoo ◽

George D. Demetri ◽

...

Keyword(s):

Quality Of Life ◽

Phase Iii ◽

Health Related Quality ◽

Gastrointestinal Stromal Tumours ◽

Phase Iii Trial ◽

Related Quality ◽

Health Related

Download Full-text

Faculty Opinions recommendation of Impact of imatinib rechallenge on health-related quality of life in patients with TKI-refractory gastrointestinal stromal tumours: Sub-analysis of the placebo-controlled, randomised phase III trial (RIGHT).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726037796.793535659 ◽

2017 ◽

Author(s):

Florence Duffaud

Keyword(s):

Quality Of Life ◽

Phase Iii ◽

Health Related Quality ◽

Gastrointestinal Stromal Tumours ◽

Phase Iii Trial ◽

Related Quality ◽

Health Related

Download Full-text